Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions. Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies
Abstract
Structure-based design, synthesis, and biological evaluation of a series of very potent HIV-1 protease inhibitors are described. In an effort to improve backbone ligand–binding site interactions, we have incorporated basic-amines at the C4 position of the bis-tetrahydrofuran (bis-THF) ring. We speculated that these substituents would make hydrogen bonding interactions in the flap region of HIV-1 protease. Synthesis of these inhibitors was performed diastereoselectively. A number of inhibitors displayed very potent enzyme inhibitory and antiviral activity. Inhibitors 25f, 25i, and 25j were evaluated against a number of highly-PI-resistant HIV-1 strains, and they exhibited improved antiviral activity over darunavir. Two high resolution X-ray structures of 25f- and 25g-bound HIV-1 protease revealed unique hydrogen bonding interactions with the backbone carbonyl group of Gly48 as well as with the backbone NH of Gly48 in the flap region of the enzyme active site. These ligand–binding site interactions are possibly responsible for their potent activity.
- Authors:
-
- Purdue Univ., West Lafayette, IN (United States)
- Georgia State Univ., Atlanta, GA (United States)
- Kumamoto Univ. (Japan); National Center for Global Health and Medicine, Tokyo (Japan)
- Kumamoto Health Science Univ. (Japan)
- Publication Date:
- Research Org.:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1222022
- Resource Type:
- Accepted Manuscript
- Journal Name:
- J. Med. Chem.
- Additional Journal Information:
- Journal Volume: 58; Journal Issue: 17
- Country of Publication:
- United States
- Language:
- ENGLISH
Citation Formats
Ghosh, Arun K., Martyr, Cuthbert D., Osswald, Heather L., Sheri, Venkat Reddy, Kassekert, Luke A., Chen, Shujing, Agniswamy, Johnson, Wang, Yuan-Fang, Hayashi, Hironori, Aoki, Manabu, Weber, Irene T., and Mitsuya, Hiroaki. Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions. Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies. United States: N. p., 2015.
Web. doi:10.1021/acs.jmedchem.5b00900.
Ghosh, Arun K., Martyr, Cuthbert D., Osswald, Heather L., Sheri, Venkat Reddy, Kassekert, Luke A., Chen, Shujing, Agniswamy, Johnson, Wang, Yuan-Fang, Hayashi, Hironori, Aoki, Manabu, Weber, Irene T., & Mitsuya, Hiroaki. Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions. Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies. United States. https://doi.org/10.1021/acs.jmedchem.5b00900
Ghosh, Arun K., Martyr, Cuthbert D., Osswald, Heather L., Sheri, Venkat Reddy, Kassekert, Luke A., Chen, Shujing, Agniswamy, Johnson, Wang, Yuan-Fang, Hayashi, Hironori, Aoki, Manabu, Weber, Irene T., and Mitsuya, Hiroaki. Fri .
"Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions. Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies". United States. https://doi.org/10.1021/acs.jmedchem.5b00900. https://www.osti.gov/servlets/purl/1222022.
@article{osti_1222022,
title = {Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions. Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies},
author = {Ghosh, Arun K. and Martyr, Cuthbert D. and Osswald, Heather L. and Sheri, Venkat Reddy and Kassekert, Luke A. and Chen, Shujing and Agniswamy, Johnson and Wang, Yuan-Fang and Hayashi, Hironori and Aoki, Manabu and Weber, Irene T. and Mitsuya, Hiroaki},
abstractNote = {Structure-based design, synthesis, and biological evaluation of a series of very potent HIV-1 protease inhibitors are described. In an effort to improve backbone ligand–binding site interactions, we have incorporated basic-amines at the C4 position of the bis-tetrahydrofuran (bis-THF) ring. We speculated that these substituents would make hydrogen bonding interactions in the flap region of HIV-1 protease. Synthesis of these inhibitors was performed diastereoselectively. A number of inhibitors displayed very potent enzyme inhibitory and antiviral activity. Inhibitors 25f, 25i, and 25j were evaluated against a number of highly-PI-resistant HIV-1 strains, and they exhibited improved antiviral activity over darunavir. Two high resolution X-ray structures of 25f- and 25g-bound HIV-1 protease revealed unique hydrogen bonding interactions with the backbone carbonyl group of Gly48 as well as with the backbone NH of Gly48 in the flap region of the enzyme active site. These ligand–binding site interactions are possibly responsible for their potent activity.},
doi = {10.1021/acs.jmedchem.5b00900},
journal = {J. Med. Chem.},
number = 17,
volume = 58,
place = {United States},
year = {Fri Oct 30 00:00:00 EDT 2015},
month = {Fri Oct 30 00:00:00 EDT 2015}
}
Web of Science
Works referenced in this record:
Strategies for antiviral therapy in AIDS
journal, February 1987
- Mitsuya, Hiroaki; Broder, Samuel
- Nature, Vol. 325, Issue 6107
Active human immunodeficiency virus protease is required for viral infectivity.
journal, July 1988
- Kohl, N. E.; Emini, E. A.; Schleif, W. A.
- Proceedings of the National Academy of Sciences, Vol. 85, Issue 13
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
journal, August 2010
- Montaner, Julio SG; Lima, Viviane D.; Barrios, Rolando
- The Lancet, Vol. 376, Issue 9740
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
journal, March 2006
- Collaboration, Art-Linc
- The Lancet, Vol. 367, Issue 9513, p. 817-824
Current status and challenges of antiretroviral research and therapy
journal, January 2010
- Esté, José A.; Cihlar, Tomas
- Antiviral Research, Vol. 85, Issue 1
Why do patients fail HIV therapy?: Why do patients fail HIV therapy?
journal, May 2007
- Waters, L.; Nelson, M.
- International Journal of Clinical Practice, Vol. 61, Issue 6
Principles and practice of HIV-protease inhibitor pharmacoenhancement: HIV-protease inhibitor pharmacoenhancement
journal, April 2001
- Moyle, Gj; Back, D.
- HIV Medicine, Vol. 2, Issue 2
Mortality and progression to AIDS after starting highly active antiretroviral therapy
journal, January 2003
- van Sighem, Ard I.; van de Wiel, Mark A.; Ghani, Azra C.
- AIDS, Vol. 17, Issue 15
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults
journal, December 1999
- Staszewski, Schlomo; Morales-Ramirez, Javier; Tashima, Karen T.
- New England Journal of Medicine, Vol. 341, Issue 25
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
journal, January 2010
- Wensing, Annemarie M. J.; van Maarseveen, Noortje M.; Nijhuis, Monique
- Antiviral Research, Vol. 85, Issue 1
Bis-Tetrahydrofuran: a Privileged Ligand for Darunavir and a New Generation of HIV Protease Inhibitors That Combat Drug Resistance
journal, September 2006
- Ghosh, Arun K.; Ramu Sridhar, Perali; Kumaragurubaran, Nagaswamy
- ChemMedChem, Vol. 1, Issue 9
Structure-Based Design of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance
journal, August 2006
- Ghosh, Arun K.; Sridhar, Perali Ramu; Leshchenko, Sofiya
- Journal of Medicinal Chemistry, Vol. 49, Issue 17
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
journal, December 2007
- Ghosh, Arun K.; Dawson, Zachary L.; Mitsuya, Hiroaki
- Bioorganic & Medicinal Chemistry, Vol. 15, Issue 24
Novel bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro
journal, September 2003
- Koh, Y.; Nakata, H.; Maeda, K.
- Antimicrobial Agents and Chemotherapy, Vol. 47, Issue 10
TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates
journal, May 2005
- De Meyer, S.; Azijn, H.; Surleraux, D.
- Antimicrobial Agents and Chemotherapy, Vol. 49, Issue 6
High Resolution Crystal Structures of HIV-1 Protease with a Potent Non-peptide Inhibitor (UIC-94017) Active Against Multi-drug-resistant Clinical Strains
journal, April 2004
- Tie, Yunfeng; Boross, Peter I.; Wang, Yuan-Fang
- Journal of Molecular Biology, Vol. 338, Issue 2
Enhancing Protein Backbone Binding-A Fruitful Concept for Combating Drug-Resistant HIV
journal, January 2012
- Ghosh, Arun K.; Anderson, David D.; Weber, Irene T.
- Angewandte Chemie International Edition, Vol. 51, Issue 8
Design of HIV Protease Inhibitors Targeting Protein Backbone: An Effective Strategy for Combating Drug Resistance
journal, January 2008
- Ghosh, Arun K.; Chapsal, Bruno D.; Weber, Irene T.
- Accounts of Chemical Research, Vol. 41, Issue 1
Design, Synthesis, and X-ray Structure of Substituted Bis-tetrahydrofuran (Bis-THF)-Derived Potent HIV-1 Protease Inhibitors
journal, January 2011
- Ghosh, Arun K.; Martyr, Cuthbert D.; Steffey, Melinda
- ACS Medicinal Chemistry Letters, Vol. 2, Issue 4
Design of gem -Difluoro- bis -Tetrahydrofuran as P2 Ligand for HIV-1 Protease Inhibitors to Improve Brain Penetration: Synthesis, X-ray Studies, and Biological Evaluation
journal, October 2014
- Ghosh, Arun K.; Yashchuk, Sofiya; Mizuno, Akira
- ChemMedChem, Vol. 10, Issue 1
GRL-04810 and GRL-05010, Difluoride-Containing Nonpeptidic HIV-1 Protease Inhibitors (PIs) That Inhibit the Replication of Multi-PI-Resistant HIV-1 In Vitro and Possess Favorable Lipophilicity That May Allow Blood-Brain Barrier Penetration
journal, September 2013
- Salcedo Gómez, Pedro Miguel; Amano, Masayuki; Yashchuk, Sofiya
- Antimicrobial Agents and Chemotherapy, Vol. 57, Issue 12
Synthesis of 1,2- O -Isopropylidene-L-threitol and its Conversion to ( R )-1,2- O -Isopropylideneglycerol
journal, January 1985
- Al-Hakim, Ali H.; Haines, Alan H.; Morley, Christopher
- Synthesis, Vol. 1985, Issue 02
Cesium promoted O-alkylation of alcohols for the efficient ether synthesis
journal, March 1999
- Dueno, Eric E.; Chu, Feixia; Kim, Seok-In
- Tetrahedron Letters, Vol. 40, Issue 10
Asymmetric Induction in the [2,3] Wittig Rearrangement by Chiral Substituents in the Allyl Moiety
journal, February 1988
- Brückner, Reinhard; Priepke, Henning
- Angewandte Chemie International Edition in English, Vol. 27, Issue 2
Asymmetric Induction and Simple Diastereoselectivity in the [2,3] Wittig Rearrangement of Ester Enolates
journal, April 1989
- Brückner, Reinhard
- Chemische Berichte, Vol. 122, Issue 4
Mitsunobu and Related Reactions: Advances and Applications
journal, June 2009
- Swamy, K. C. Kumara; Kumar, N. N. Bhuvan; Balaraman, E.
- Chemical Reviews, Vol. 109, Issue 6
A Convergent Synthesis of (+)-Cryptophycin B, a Potent Antitumor Macrolide from Nostoc sp. Cyanobacteria
journal, June 2000
- Ghosh, Arun K.; Bischoff, Alexander
- Organic Letters, Vol. 2, Issue 11
A simple, continuous fluorometric assay for HIV protease
journal, December 1990
- Toth, Mihaly V.; Marshall, Garland R.
- International Journal of Peptide and Protein Research, Vol. 36, Issue 6
The role of dolutegravir in the management of HIV infections
journal, February 2015
- Miller, Misty; Liedtke, Michelle D.; Rathbun, R. Chris
- Infection and Drug Resistance
Prevalence of Darunavir Resistance–Associated Mutations: Patterns of Occurrence and Association with Past Treatment
journal, October 2007
- Mitsuya, Yumi; Liu, Tommy F.; Rhee, Soo‐Yon
- The Journal of Infectious Diseases, Vol. 196, Issue 8
In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple Conventional Protease Inhibitors
journal, September 2010
- Koh, Y.; Amano, M.; Towata, T.
- Journal of Virology, Vol. 84, Issue 22
Amino Acid Substitutions in Gag Protein at Non-cleavage Sites Are Indispensable for the Development of a High Multitude of HIV-1 Resistance against Protease Inhibitors
journal, February 2002
- Gatanaga, Hiroyuki; Suzuki, Yasuhiro; Tsang, Hsinyi
- Journal of Biological Chemistry, Vol. 277, Issue 8
Loss of Protease Dimerization Inhibition Activity of Darunavir Is Associated with the Acquisition of Resistance to Darunavir by HIV-1
journal, August 2011
- Koh, Y.; Aoki, M.; Danish, M. L.
- Journal of Virology, Vol. 85, Issue 19
Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir
journal, August 2014
- Hayashi, H.; Takamune, N.; Nirasawa, T.
- Proceedings of the National Academy of Sciences, Vol. 111, Issue 33
Structural implications of drug-resistant mutants of HIV-1 protease: High-resolution crystal structures of the mutant protease/substrate analogue complexes
journal, January 2001
- Mahalingam, Bhuvaneshwari; Louis, John M.; Hung, Jason
- Proteins: Structure, Function, and Genetics, Vol. 43, Issue 4
Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters: HIV protease mutants altering hydrophobic clusters
journal, August 2010
- Shen, Chen-Hsiang; Wang, Yuan-Fang; Kovalevsky, Andrey Y.
- FEBS Journal, Vol. 277, Issue 18
Phaser crystallographic software
journal, July 2007
- McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
- Journal of Applied Crystallography, Vol. 40, Issue 4
Overview of the CCP 4 suite and current developments
journal, March 2011
- Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
- Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
A graphical user interface to the CCP 4 program suite
journal, June 2003
- Potterton, Elizabeth; Briggs, Peter; Turkenburg, Maria
- Acta Crystallographica Section D Biological Crystallography, Vol. 59, Issue 7
Features and development of Coot
journal, March 2010
- Emsley, P.; Lohkamp, B.; Scott, W. G.
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
PRODRG : a tool for high-throughput crystallography of protein–ligand complexes
journal, July 2004
- Schüttelkopf, Alexander W.; van Aalten, Daan M. F.
- Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 8
Works referencing / citing this record:
Nature Inspired Molecular Design: Stereoselective Synthesis of Bicyclic and Polycyclic Ethers for Potent HIV-1 Protease Inhibitors
journal, June 2018
- Ghosh, Arun K.; Brindisi, Margherita
- Asian Journal of Organic Chemistry, Vol. 7, Issue 8
Novel Protease Inhibitors Containing C-5-Modified bis -Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2′ Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance
journal, May 2019
- Takamatsu, Yuki; Aoki, Manabu; Bulut, Haydar
- Antimicrobial Agents and Chemotherapy, Vol. 63, Issue 8